Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-15 Sale | 2024-11-19 9:57 pm | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 43,396 | $4.9925 | $216,652 | 166,342 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-28 Option Award | 2024-10-30 8:32 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
2024-02-29 Option Award(A) | 2024-03-04 06:15 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 100,000 | $0 | 284,738 (Direct) | View |
2024-02-29 Option Award | 2024-03-01 6:42 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 100,000 | $0 | 285,738 (Direct) | View |
2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 160,262 | $0 | 231,174 (Direct) | View |
2023-08-25 Option Award | 2023-08-29 6:53 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 16,727,648 | $0 | 17,727,648 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 6:59 pm | N/A 2031-12-14 | Skye Bioscience Inc. | SKYE | Arsenault Kaitlyn Melanie Chief Financial Officer | 2,770,000 | $0 | 2,770,000 (Direct) | View |
2021-10-04 Option Award | 2021-10-05 8:42 pm | N/A 2031-10-04 | Skye Bioscience Inc. | SKYE | Arsenault Kaitlyn Melanie Chief Financial Officer | 1,600,000 | $0 | 2,000,000 (Direct) | View |
Ownership | 2021-10-05 8:40 pm | N/A 2031-09-14 | Skye Bioscience Inc. | SKYE | Arsenault Kaitlyn Melanie Chief Financial Officer | 0 | $0 | 400,000 (Direct) | View |